Home › Free Stock Grades › MDXG
MiMedx Group, Inc. (MDXG) Stock Grade
MDXG · Healthcare
A+
Market Cap
$1.0B
P/E Ratio
20.6
Revenue Growth (YoY)
+20.0%
Net Margin
11.6%
Return on Equity
18.9%
Dividend Yield
None
About MiMedx Group, Inc.'s fundamentals
MiMedx Group is a biotechnology company with a $1.0 billion market valuation that demonstrates solid profitability metrics, including an 11.6% net margin and 18.9% return on equity. The company is growing revenue at a strong 20.0% year-over-year rate while trading at a P/E ratio of 20.6. The company does not currently pay a dividend to shareholders.